After India lost its dominance in making penicillin, a drought of three decades is coming to an end. The drug – which forms the base for a raft of extremely potent antibiotics – is part of the governments aggressive push for self-sufficiency in critical areas. Will the plan to claw back to the glorious past work?
With the chipmaker dominating the AI processor market, startups in the sector are raising more money and devoting increasing portions of it to hardware — leaving less for everything else.
With the chipmaker dominating the AI processor market, startups in the sector are raising more money and devoting increasing portions of it to hardware — leaving less for everything else.
Sales software maker Alembic to double staff in San Francisco after raising $14M. The startup has designed an AI system that analyzes data to predict the return on investment of marketing messages.
The Vadodra-based pharma manufacturer does not foresee additional capital expenditure for these initiatives but is shifting its strategic focus on new generation drugs over legacy products